PetMed Express (NASDAQ:PETS) Stock Rating Upgraded by StockNews.com

PetMed Express (NASDAQ:PETS) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Tuesday.

Separately, Lake Street Capital reaffirmed a “hold” rating and set a $3.50 target price (down from $7.00) on shares of PetMed Express in a report on Wednesday, August 7th.

PetMed Express Stock Up 2.0 %

NASDAQ PETS opened at $5.28 on Tuesday. PetMed Express has a twelve month low of $2.90 and a twelve month high of $8.27. The company has a market cap of $108.98 million, a price-to-earnings ratio of -87.92 and a beta of 0.68. The business’s fifty day moving average is $3.98 and its 200 day moving average is $3.92.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. The company had revenue of $59.57 million for the quarter, compared to the consensus estimate of $66.02 million. On average, research analysts anticipate that PetMed Express will post 0.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, major shareholder Nina Capital Holdings Inc. bought 12,500 shares of the business’s stock in a transaction on Monday, September 9th. The shares were purchased at an average cost of $3.34 per share, with a total value of $41,750.00. Following the acquisition, the insider now owns 2,078,000 shares of the company’s stock, valued at $6,940,520. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Independent Advisor Alliance bought a new position in shares of PetMed Express in the 3rd quarter worth about $106,000. Bleakley Financial Group LLC bought a new stake in PetMed Express during the 3rd quarter worth approximately $279,000. Point72 DIFC Ltd bought a new stake in PetMed Express during the 2nd quarter worth approximately $34,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of PetMed Express in the 2nd quarter worth approximately $135,000. Finally, Squarepoint Ops LLC purchased a new position in shares of PetMed Express in the 2nd quarter worth approximately $273,000. 73.33% of the stock is owned by institutional investors.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.